Hi-Tech Pharmaceuticals | 60 Tablets

Hi-Tech Pharmaceuticals Arimistane is a deliberately minimalist hormonal support formula: one disclosed active, one clear dose, and a delivery system engineered to make that dose actually count. The single active is Androsta-3,5-dien-7,17-dione — branded Arimistane — at 50mg per tablet across a 60-tablet bottle. This is not a multi-ingredient PCT cocktail; it is a dedicated aromatase-inhibiting compound for people who want surgical control over estrogen rather than a broad, diluted approach.

The mechanism is what makes this category interesting. Aromatase (the CYP19A1 enzyme) is the gatekeeper that converts androgens like testosterone and androstenedione into estrogens such as estradiol and estrone. Arimistane is classified as a suicidal (irreversible) aromatase inhibitor — it binds to the enzyme and permanently inactivates it, meaning the body must synthesize new aromatase enzyme to recover that conversion capacity. The practical consequence is lower circulating estrogen. Because estrogen exerts negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis, reducing it can lift the brakes on GnRH, which in turn supports luteinizing hormone (LH) output and the testicular drive to produce more natural testosterone — exactly why Hi-Tech files this ingredient under 'Testosterone and LH Support & Aromatase Inhibitor.' Arimistane is structurally related to the 7-oxo/DHEA metabolite family. Some compounds in this class, notably 7-keto-DHEA (a distinct molecule), have been studied for cortisol-modulating activity; whether arimistane itself shares this property has not been established in direct human research. The drier, harder look users report is most directly attributable to the reduction in estrogen-driven fluid retention from aromatase inhibition. At 50mg, this sits squarely in the commonly used standalone and PCT range of roughly 25-75mg per day — an effective, sensible dose rather than a token sprinkle or a reckless overload.

The formulation intelligence here lives in the inactive list. Phosphatidylcholine 75% and Hydroxypropyl Beta-Cyclodextrin (HPβCD) are the two halves of Hi-Tech's Cyclosome delivery technology. Steroidal and steroid-like compounds are notoriously poorly water-soluble and heavily metabolized on first pass through the liver, which historically wrecked the oral bioavailability of compounds like this. Cyclosome addresses both problems: the cyclodextrin complexes the lipophilic molecule to improve solubility, while the phosphatidylcholine forms a liposomal carrier that favors lymphatic uptake and helps the payload bypass aggressive first-pass degradation. Phytosterols round out the lipid matrix. The point is that the 50mg on the label is engineered to be 50mg your bloodstream can use.

The synergy story is simple but real: the active supports normal estrogen balance, the delivery system makes the active bioavailable, and the lipid carriers support absorption of a compound that would otherwise struggle to get into circulation. There is no stimulant, no proprietary blend, and no padding.

On transparency, this product is exemplary for its category. Despite metadata flags suggesting a proprietary blend, the verified label shows a single named active at an exact 50mg dose — full disclosure, nothing hidden. In a hormonal-support market littered with under-labeled blends, that clarity is a genuine advantage.

What to expect: this is a cumulative compound, not a pre-workout. Within the first few days, many users notice reduced water retention and a tighter look. Across two to four weeks of consistent daily dosing, the estrogen-management and LH/testosterone-support effects build — a drier physique, reduced estrogenic water retention on or after cycle, and the kind of hardness that lower estradiol produces. Run it as a defined cycle, not indefinitely.

The mechanistic descriptions above reflect established general pharmacology of aromatase inhibition and HPG-axis biology. No human clinical trials specific to arimistane at this dose appear in the available research record for this product. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.